Biomarkers Related to Endothelial Dysfunction and Vascular Cognitive Impairment: A Systematic Review

Rui Kleber Martins-Filho1, Maria Clara Zotin2, Guilherme Rodrigues3

  • 1Department of Neurosciences and Behavioural Sciences, Hospital das Clínicas - Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, ruikleber@usp.br.

Insights

Biomarkers show a link between endothelial dysfunction and vascular cognitive impairment (VCI). More research is needed to find specific markers for better diagnosis and new treatments for VCI.

Area of Science:

  • Neurology
  • Biomarker Research
  • Vascular Dementia

Background:

  • Endothelial damage and neurovascular unit dysfunction are central to vascular cognitive impairment (VCI) pathogenesis.
  • Despite advances, unanswered questions and diagnostic challenges hinder VCI comprehension and treatment development.
  • Biomarker investigation is crucial for novel VCI models and therapeutic targets.

Purpose of the Study:

  • To review current research on biomarkers for vascular cognitive impairment (VCI).
  • To synthesize findings on various types of VCI biomarkers.
  • To identify gaps in biomarker research for improved VCI diagnosis and treatment.

Main Methods:

  • Conducted a systematic literature search of MEDLINE for VCI biomarker research over the past 20 years.
  • Included original research adhering to prespecified selection criteria.
  • Performed qualitative synthesis of extracted data.

Main Results:

  • Reviewed 42 articles focusing on VCI biomarkers.
  • Investigated plasma (16), neuropathological (17), CSF (4), and neuroimaging (4) markers.
  • Included one study on peripheral Doppler perfusion imaging.

Conclusions:

  • Biomarker studies indicate a strong association between endothelial dysfunction and VCI.
  • A distinct set of biomarkers is needed to enhance VCI clinical approaches and diagnostic accuracy.
  • Further biomarker identification is essential for developing alternative VCI therapies.
Abstract